Paper28617852
Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.
Zhang W and 8 others. PLoS One, 2017. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells. Papers, record 28617852. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28617852
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dicumarol | Major topic |
| Neoplasm Proteins | Major topic |
| Ovarian Neoplasms | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Apoptosis | |
| Cell Line, Tumor | |
| Cell Survival | |
| Female | |
| Glucose | |
| Glycolysis | |
| Humans | |
| Mitochondrial Membranes | |
| Pyruvate Dehydrogenase Acetyl-Transferring Kinase | |
| Reactive Oxygen Species |
Source PubMed
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27637302 | The History of Antithrombotic Therapy: The Discovery of Heparin, the Vitamin K Antagonists, and the Utility of Aspirin. | Hematol Oncol Clin North Am | 2016 | https://conductscience.org/library/papers/27637302 | PubMed |
| 2 | 23534412 | Antithrombotic activity of a newly synthesized coumarin derivative 3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-N-{2-[3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino]-ethyl}-propionamide. | Chem Biol Drug Des | 2013 | https://conductscience.org/library/papers/23534412 | PubMed |
| 3 | 26483203 | JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification. | Cancer Res | 2015 | https://conductscience.org/library/papers/26483203 | PubMed |
| 4 | 19657231 | HIF-1 prevents the overproduction of mitochondrial ROS after cytokine stimulation through induction of PDK-1. | Cell Cycle | 2009 | https://conductscience.org/library/papers/19657231 | PubMed |
| 5 | 27874079 | Crosstalk among proteome, acetylome and succinylome in colon cancer HCT116 cell treated with sodium dichloroacetate. | Sci Rep | 2016 | https://conductscience.org/library/papers/27874079 | PubMed |
| 6 | 21798343 | Developmental effects of coumarin and the anticoagulant coumarin derivative warfarin on zebrafish (Danio rerio) embryos. | Reprod Toxicol | 2012 | https://conductscience.org/library/papers/21798343 | PubMed |
| 7 | 17222789 | A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. | Cancer Cell | 2007 | https://conductscience.org/library/papers/17222789 | PubMed |
| 8 | 26959013 | Computational Study on New Natural Compound Inhibitors of Pyruvate Dehydrogenase Kinases. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/26959013 | PubMed |
| 9 | 21904029 | Inhibitor-bound structures of human pyruvate dehydrogenase kinase 4. | Acta Crystallogr D Biol Crystallogr | 2011 | https://conductscience.org/library/papers/21904029 | PubMed |
| 10 | 16518417 | Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines. | Oncogene | 2006 | https://conductscience.org/library/papers/16518417 | PubMed |
| 12 | 22240028 | Protein profiles in human ovarian cancer cell lines correspond to their metabolic activity and to metabolic profiles of respective tumor xenografts. | FEBS J | 2012 | https://conductscience.org/library/papers/22240028 | PubMed |
| 13 | 2578093 | Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro. | Cancer Res | 1985 | https://conductscience.org/library/papers/2578093 | PubMed |
| 14 | 24463645 | Synthesis, structure-activity relationship of iodinated-4-aryloxymethyl-coumarins as potential anti-cancer and anti-mycobacterial agents. | Eur J Med Chem | 2014 | https://conductscience.org/library/papers/24463645 | PubMed |
| 15 | 26681918 | Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target? | Int J Biol Sci | 2015 | https://conductscience.org/library/papers/26681918 | PubMed |
| 16 | 27653744 | Targeting PSG1 to enhance chemotherapeutic efficacy: new application for anti-coagulant the dicumarol. | Clin Sci (Lond) | 2016 | https://conductscience.org/library/papers/27653744 | PubMed |
| 17 | 26188907 | Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies. | Eur J Med Chem | 2015 | https://conductscience.org/library/papers/26188907 | PubMed |
| 18 | 25404640 | VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cells. | Oncotarget | 2014 | https://conductscience.org/library/papers/25404640 | PubMed |
| 19 | 26750139 | Historical Hallmarks of Anticoagulation and Antiplatelet Agents. | Curr Pharm Des | 2016 | https://conductscience.org/library/papers/26750139 | PubMed |
| 20 | 1600837 | Dichloroacetate. | Diabetes Care | 1992 | https://conductscience.org/library/papers/1600837 | PubMed |
| 21 | 19341700 | Monitoring phosphorylation of the pyruvate dehydrogenase complex. | Anal Biochem | 2009 | https://conductscience.org/library/papers/19341700 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42683253 | Natural compounds targeting glycolysis and TME in ovarian cancer: from metabolic crosstalk to therapeutic potential. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42683253 | PubMed |
| 42630972 | The Mechanisms of Ramulus Cinnamomi and Rhizoma Paridis in Gynecological Cancers: A Narrative Review. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42630972 | PubMed |
| 42545560 | Liraglutide affects mitochondrial function and histone acetylation through the NQO1/SIRT3 pathway in diabetic kidney disease. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/42545560 | PubMed |
| 42317327 | Glycolytic reprogramming in ovarian cancer: mechanisms, immune crosstalk, and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42317327 | PubMed |
| 42007213 | The role of circadian disruption, sleep dysregulation, lifestyle factors, and metabolic reprogramming in the pathogenesis and progression of ovarian cancer. | J Natl Cancer Cent | 2026 | https://conductscience.org/library/papers/42007213 | PubMed |
| 41756460 | Mechanism of action of two potent LRRC8/VRAC channel inhibitors. | Res Sq | 2026 | https://conductscience.org/library/papers/41756460 | PubMed |
| 41465397 | Herbal Composition Inhibits Mitochondrial Oxidative Phosphorylation to Prevent HER2-Positive Breast Cancer and Identifies Potential Active Compounds. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465397 | PubMed |
| 40631551 | Target identification of natural products in cancer with chemical proteomics and artificial intelligence approaches. | Cancer Biol Med | 2025 | https://conductscience.org/library/papers/40631551 | PubMed |
| 40314877 | Lactic acid metabolism: gynecological cancer's Achilles' heel. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40314877 | PubMed |
| 40225420 | In silico docking, ADMET profiling, and bio-accessibility experimentation on Breynia retusa phytocompounds and in vitro validation for anti-proliferative potencies against ovarian carcinoma. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40225420 | PubMed |
| 40103473 | Antimicrobial Plant Peptides: Structure, Classification, Mechanism and Therapeutic Potential. | Curr Top Med Chem | 2025 | https://conductscience.org/library/papers/40103473 | PubMed |
| 39835210 | Incredible use of plant-derived bioactives as anticancer agents. | RSC Adv | 2025 | https://conductscience.org/library/papers/39835210 | PubMed |
| 39364049 | A comprehensive review on the potential of coumarin and related derivatives as multi-target therapeutic agents in the management of gynecological cancers. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39364049 | PubMed |
| 39206407 | Notch Signaling Suppression by Golden Phytochemicals: Potential for Cancer Therapy. | Adv Pharm Bull | 2024 | https://conductscience.org/library/papers/39206407 | PubMed |
| 38279745 | Phytotherapeutics in Cancer: From Potential Drug Candidates to Clinical Translation. | Curr Top Med Chem | 2024 | https://conductscience.org/library/papers/38279745 | PubMed |
| 38090580 | Research progress on the mechanism of glycolysis in ovarian cancer. | Front Immunol | 2023 | https://conductscience.org/library/papers/38090580 | PubMed |
| 37475858 | Growth hormone remodels the 3D-structure of the mitochondria of inflammatory macrophages and promotes metabolic reprogramming. | Front Immunol | 2023 | https://conductscience.org/library/papers/37475858 | PubMed |
| 37259418 | Phenolic Acids-Mediated Regulation of Molecular Targets in Ovarian Cancer: Current Understanding and Future Perspectives. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37259418 | PubMed |
| 36575479 | Dicoumarol: from chemistry to antitumor benefits. | Chin Med | 2022 | https://conductscience.org/library/papers/36575479 | PubMed |
| 36406733 | Recent advances in understanding the metabolic plasticity of ovarian cancer: A systematic review. | Heliyon | 2022 | https://conductscience.org/library/papers/36406733 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28617852
GET https://conductscience.org/api/papers/v1/28617852/references?page=2